Sexual Dysfunction in Young Adult Men
Prevalence and Associated Factors of Sexual Dysfunction in Sexually Active Men Aged 18 to 40 Years: A Single-Center Cross-Sectional Study
This single-center cross-sectional study aims to determine the prevalence of erectile dysfunction and premature ejaculation in sexually active men aged 18 to 40 years and to evaluate their association with depressive and anxiety symptoms, lifestyle factors, and sociodemographic characteristics. Participants attending outpatient clinics of Ondokuz Mayis University Hospital for routine health check-ups completed a structured questionnaire, the International Index of Erectile Function-15 (IIEF-15), the Premature Ejaculation Diagnostic Tool (PEDT), the Beck Depression Inventory, and the Generalized Anxiety Disorder-7 (GAD-7) scale.
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Samsun, Turkey (Türkiye), 55150
- Ondokuz Mayis University Faculty of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Sexually active men aged 18 to 40 years attending outpatient clinics of Ondokuz Mayis University Hospital for routine health check-ups.
Description
Inclusion Criteria:
- Inclusion Criteria:
- Male, aged 18 to 40 years
- Sexual activity within the previous six months
- Attending Ondokuz Mayis University Hospital outpatient clinics for a routine health check-up
- Ability to read and write Turkish and to complete the questionnaire
- Written informed consent
Exclusion Criteria:
- History of spinal cord injury
- Active cancer or ongoing chemotherapy/radiotherapy
- Cognitive, psychiatric, or communication impairment preventing reliable completion of the questionnaire
- Incomplete or inconsistent questionnaire data precluding analysis
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Observational Models: OTHER
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Sexually active men aged 18-40 years
Men attending outpatient clinics for routine health check-ups who completed IIEF-15, PEDT, Beck Depression Inventory and GAD-7. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of erectile dysfunction
Time Frame: At enrollment (single cross-sectional assessment)
|
Proportion of participants with an IIEF-15 erectile function domain score of 25 or lower. |
At enrollment (single cross-sectional assessment)
|
|
Prevalence of premature ejaculation
Time Frame: At enrollment (single cross-sectional assessment)
|
Proportion of participants with a PEDT total score of 11 or higher. |
At enrollment (single cross-sectional assessment)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Association of anxiety symptoms with sexual dysfunction
Time Frame: At enrollment
|
Association of GAD-7 score (10 or higher defined as anxiety) with erectile dysfunction and premature ejaculation. |
At enrollment
|
|
Association of depressive symptoms with sexual dysfunction
Time Frame: At enrollment
|
Association of Beck Depression Inventory score (17 or higher defined as depression) with erectile dysfunction and premature ejaculation. |
At enrollment
|
|
Association of lifestyle and sociodemographic factors with sexual dysfunction
Time Frame: At enrollment
|
Association of BMI, waist circumference, smoking, alcohol use, physical activity, working pattern, weekly working hours, education, income and marital status with erectile dysfunction and premature ejaculation. |
At enrollment
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- OMUKAEK-2026-272
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data will not be shared publicly as participant consent did not include public data sharing.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.